https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-11-23 16:38:392016-11-25 16:38:582012 AACR: Chemosensitizing effects of DNA methylation inhibitor SGI-110 in Ovarian Cancer
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-11-20 16:39:062016-11-25 16:39:262012 AACR: SGI-110, a novel SQ second generation DNA hypomethylating agent
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-11-15 16:39:312016-11-25 16:39:522012 AACR: Scale up & development of a process for a low volume subcutaneous formulation of SGI-110
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-10-25 14:34:492016-11-25 14:35:082012 EORTC: Characterization of a Potent XIAP & cIAP1 Dual Antagonist in Melanoma and Leukemia
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-09-25 15:21:552016-11-25 15:22:222012 ASCO:FIH phase I study-results of HSP90 inhibitor AT13387 in refractory solid tumors
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-08-25 14:35:182016-11-25 14:35:362012 AACR: Discovery of potent dual inhibitors of both XIAP and cIAP using fragment based
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-07-25 15:22:442016-11-25 15:23:152012 ASCO: Phase I Study Assessing QDx2 schedule of AT13387 in Advanced Solid Tumors
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-06-25 14:35:462016-11-25 14:36:042012 TAT: Discovery of Dual Antagonist of both XIAP and cIAP Using Fragment Based Drug Discovery
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2012-05-25 15:23:292016-11-25 15:23:552012 AACR: AT13387, HSP90 inhibitor effective in vemurafenib-sensitive and -resistant melanoma model
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
